BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 20817929)

  • 21. Direct proteasome binding and subsequent degradation of unspliced XBP-1 prevent its intracellular aggregation.
    Navon A; Gatushkin A; Zelcbuch L; Shteingart S; Farago M; Hadar R; Tirosh B
    FEBS Lett; 2010 Jan; 584(1):67-73. PubMed ID: 19941857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid turnover of unspliced Xbp-1 as a factor that modulates the unfolded protein response.
    Tirosh B; Iwakoshi NN; Glimcher LH; Ploegh HL
    J Biol Chem; 2006 Mar; 281(9):5852-60. PubMed ID: 16332684
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of XBP-1 signaling during transient and stable recombinant protein production in CHO cells.
    Ku SC; Toh PC; Lee YY; Chusainow J; Yap MG; Chao SH
    Biotechnol Prog; 2010; 26(2):517-26. PubMed ID: 19938059
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The p300/CBP-associated factor (PCAF) is a cofactor of ATF4 for amino acid-regulated transcription of CHOP.
    Chérasse Y; Maurin AC; Chaveroux C; Jousse C; Carraro V; Parry L; Deval C; Chambon C; Fafournoux P; Bruhat A
    Nucleic Acids Res; 2007; 35(17):5954-65. PubMed ID: 17726049
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The differentiation and stress response factor XBP-1 drives multiple myeloma pathogenesis.
    Carrasco DR; Sukhdeo K; Protopopova M; Sinha R; Enos M; Carrasco DE; Zheng M; Mani M; Henderson J; Pinkus GS; Munshi N; Horner J; Ivanova EV; Protopopov A; Anderson KC; Tonon G; DePinho RA
    Cancer Cell; 2007 Apr; 11(4):349-60. PubMed ID: 17418411
    [TBL] [Abstract][Full Text] [Related]  

  • 26. X-Box-Binding Protein 1 and Innate Immune Responses of Human Cystic Fibrosis Alveolar Macrophages.
    Lubamba BA; Jones LC; O'Neal WK; Boucher RC; Ribeiro CM
    Am J Respir Crit Care Med; 2015 Dec; 192(12):1449-61. PubMed ID: 26331676
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coactivators p300 and PCAF physically and functionally interact with the foamy viral trans-activator.
    Bannert H; Muranyi W; Ogryzko VV; Nakatani Y; Flügel RM
    BMC Mol Biol; 2004 Sep; 5():16. PubMed ID: 15350211
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The X-box binding protein-1 transcription factor is required for plasma cell differentiation and the unfolded protein response.
    Iwakoshi NN; Lee AH; Glimcher LH
    Immunol Rev; 2003 Aug; 194():29-38. PubMed ID: 12846805
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of ERdj3 and OBF-1/BOB-1/OCA-B as direct targets of XBP-1 during plasma cell differentiation.
    Shen Y; Hendershot LM
    J Immunol; 2007 Sep; 179(5):2969-78. PubMed ID: 17709512
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epstein-Barr virus nuclear protein 2 interacts with p300, CBP, and PCAF histone acetyltransferases in activation of the LMP1 promoter.
    Wang L; Grossman SR; Kieff E
    Proc Natl Acad Sci U S A; 2000 Jan; 97(1):430-5. PubMed ID: 10618435
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of X-box binding protein-1 in tumorigenicity.
    Shajahan AN; Riggins RB; Clarke R
    Drug News Perspect; 2009 Jun; 22(5):241-6. PubMed ID: 19609461
    [TBL] [Abstract][Full Text] [Related]  

  • 32. KLF8 recruits the p300 and PCAF co-activators to its amino terminal activation domain to activate transcription.
    Urvalek AM; Wang X; Lu H; Zhao J
    Cell Cycle; 2010 Feb; 9(3):601-11. PubMed ID: 20107328
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma cell differentiation and the unfolded protein response intersect at the transcription factor XBP-1.
    Iwakoshi NN; Lee AH; Vallabhajosyula P; Otipoby KL; Rajewsky K; Glimcher LH
    Nat Immunol; 2003 Apr; 4(4):321-9. PubMed ID: 12612580
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of glucose homeostasis through a XBP-1-FoxO1 interaction.
    Zhou Y; Lee J; Reno CM; Sun C; Park SW; Chung J; Lee J; Fisher SJ; White MF; Biddinger SB; Ozcan U
    Nat Med; 2011 Mar; 17(3):356-65. PubMed ID: 21317886
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ATF6 activated by proteolysis binds in the presence of NF-Y (CBF) directly to the cis-acting element responsible for the mammalian unfolded protein response.
    Yoshida H; Okada T; Haze K; Yanagi H; Yura T; Negishi M; Mori K
    Mol Cell Biol; 2000 Sep; 20(18):6755-67. PubMed ID: 10958673
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trichostatin A induces transforming growth factor beta type II receptor promoter activity and acetylation of Sp1 by recruitment of PCAF/p300 to a Sp1.NF-Y complex.
    Huang W; Zhao S; Ammanamanchi S; Brattain M; Venkatasubbarao K; Freeman JW
    J Biol Chem; 2005 Mar; 280(11):10047-54. PubMed ID: 15647279
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PCAF represses transactivation function of FOXO1 in an acetyltransferase-independent manner.
    Yoshimochi K; Daitoku H; Fukamizu A
    J Recept Signal Transduct Res; 2010 Feb; 30(1):43-9. PubMed ID: 20041807
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IRE1α dissociates with BiP and inhibits ER stress-mediated apoptosis in cartilage development.
    Han X; Zhou J; Zhang P; Song F; Jiang R; Li M; Xia F; Guo FJ
    Cell Signal; 2013 Nov; 25(11):2136-46. PubMed ID: 23816533
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dysregulation of unfolded protein response partially underlies proapoptotic activity of bortezomib in multiple myeloma cells.
    Dong H; Chen L; Chen X; Gu H; Gao G; Gao Y; Dong B
    Leuk Lymphoma; 2009 Jun; 50(6):974-84. PubMed ID: 19391038
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduced response of IRE1α/Xbp-1 signaling pathway to bortezomib contributes to drug resistance in multiple myeloma cells.
    Xu X; Liu J; Huang B; Chen M; Yuan S; Li X; Li J
    Tumori; 2017 May; 103(3):261-267. PubMed ID: 27647225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.